Drugs / lvonescimab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06919510 | Apr 2025 → Jun 2026 overdue | rectum adenocarcinoma | Sun Yat-sen University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lvonescimab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06919510 ↗ |
| Route | Intravenous | “intravenous infusion” NCT06919510 ↗ |